Curaleaf Holdings Files 6-K, Reports for October 2025

Ticker: CURLF · Form: 6-K · Filed: 2025-10-14T00:00:00.000Z

Sentiment: neutral

Topics: reporting, regulatory-filing

TL;DR

Curaleaf 6-K filed Oct 14, 2025. Will use Form 40-F for annual reports. Press release attached.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on October 14, 2025, reporting for the month of October 2025. The filing indicates that Curaleaf will file its annual reports under Form 40-F, not Form 20-F. The report includes a press release as Exhibit 99.1.

Why It Matters

This filing provides an update on Curaleaf's reporting status and includes a press release, which may contain material information for investors.

Risk Assessment

Risk Level: low — This is a routine filing that primarily confirms reporting procedures and includes a press release, with no immediate financial or operational disclosures that suggest high risk.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose is to report for the month of October 2025 and to indicate that Curaleaf Holdings, Inc. files its annual reports under Form 40-F.

Which form does Curaleaf Holdings, Inc. use for its annual reports?

Curaleaf Holdings, Inc. uses Form 40-F for its annual reports, as indicated by the checkmark next to 'Form 40-F' and the absence of a checkmark next to 'Form 20-F'.

Who signed this report on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed the report on behalf of Curaleaf Holdings, Inc.

What is the filing date of this report?

The filing date of this report is October 14, 2025.

What exhibits are included with this Form 6-K filing?

Exhibit 99.1, a Press Release, is included with this Form 6-K filing.

From the Filing

0001756770-25-000035.txt : 20251014 0001756770-25-000035.hdr.sgml : 20251014 20251014153240 ACCESSION NUMBER: 0001756770-25-000035 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20251014 FILED AS OF DATE: 20251014 DATE AS OF CHANGE: 20251014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 251391546 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover101425needhamcred.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: October 14, 2025 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release EX-99.1 2 a2025-10x14xcuraleafxups.htm EX-99.1 a2025-10x14xcuraleafxups Curaleaf Holdings, Inc. Investor Relations Curaleaf Upsizes Revolving Credit Facility to $100 Million with Needham Bank Represents the largest revolving credit facility in the U.S. cannabis sector to date Landmark financing marks a significant step forward for institutional lending in cannabis STAMFORD, Conn., Oct. 14, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has entered into an amended and restated credit agreement with Needham Bank of its revolving credit facility (the "Credit Facility"), expanding the borrowing capacity from $40 million to $100 million and extending the maturity to up to five years. Boris Jordan, Chairman and CEO of Curaleaf, said "I couldn't be prouder of our team for the focus, discipline, and collaboration that made completing this $100 million facility possible. Not only does this increased credit line provide us greater flexibility to execute our strategic plan but also demonstrates the confidence Needham has in our long-term objectives." "This first of-its-kind transaction of this scale in the cannabis industry was backed by the direct support and strong conviction of our lenders in our business and future," said Ed Kremer CFO of Curaleaf. "It represents a significant step toward broader access to capital markets and signals progress toward establishing financial standards in a sector that has historically faced limited institutional participation. We are proud to have longstanding partners who not only champion our vision but also contribute to the advancement of the cannabis industry. This strengthened capital position will be key to advancing our growth initiatives, enhancing operational capabilities, and preserving financial flexibility during this critica

View on Read The Filing